Home
Star Imaging And Path Lab Ltd Share Price History
BSE : 18 Aug, 2025
134.95-7.1 (-5.0%)
Prev Close
142.0
Open Price
142.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1032000
Today's High / Low
143.0 / 134.9
52 WK High / Low
143.0 / 134.9
Market Price of Star Imaging and Path Lab Ltd
1M
1Y
3Y
5Y
Monitoring Star Imaging and Path Lab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 41.95 |
| YoY Gr. | - |
| Net Profit (Cr.) | 6 |
| BVPS | 122.37 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 23.33 |
| Op. Profit Mgn % | 21.51 |
| Net Profit Mgn % | 9.1 |
| Debt to Equity % | 1.61 |
Latest Shareholding
Promoters Holdings Over Time
About Star Imaging and Path Lab Ltd
- Star Imaging and Path Lab Limited was originally incorporated as a private limited company as 'Star Imaging & Path Lab Private Limited' dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana.
- Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed to 'Star Imaging and Path Lab Limited' vide a fresh certificate of incorporation dated September 17, 2024 issued by Central Processing Centre. The Company started its journey from 1978 as proprietorship under the name of Janta X-Ray Clinic and were providing X-ray and basic pathology tests using manual methods.
- Over the years, they have upgraded their services, equipment, and diagnostic technologies to incorporate latest advancements in medical science, ensuring the care and improved patient outcomes.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Star Imaging and Path Lab Ltd's share price history?
Key events that impact Star Imaging and Path Lab Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Star Imaging and Path Lab Ltd's share price history?
Stock splits reduce the nominal price of Star Imaging and Path Lab Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Star Imaging and Path Lab Ltd?
Dividends can influence Star Imaging and Path Lab Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Star Imaging and Path Lab Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Star Imaging and Path Lab Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Star Imaging and Path Lab Ltd’s share price history?
To understand Star Imaging and Path Lab Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
